Información del producto
3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is a compound that has been shown to lower blood glucose levels in animal models and has potent oral efficacy, as well as agonistic activity at the GLP-1 receptor. It is currently in phase II clinical trials for the treatment of type 2 diabetes. 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is an orally active compound that lowers glucose levels by stimulating insulin secretion and enhancing insulin sensitivity in liver cells. It has been shown to have a conformationally restricted agonist activity at the GLP-1 receptor, which may be due to its structural similarity to octane, a ligand for this receptor
Propiedades químicas
Consulta técnica sobre: 3D-WZB18779 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.